Toward patient-centered drug development in oncology

N Engl J Med. 2013 Aug 1;369(5):397-400. doi: 10.1056/NEJMp1114649. Epub 2013 Jul 3.
No abstract available

MeSH terms

  • Antineoplastic Agents* / adverse effects
  • Antineoplastic Agents* / therapeutic use
  • Drug Approval
  • Drug Discovery*
  • Humans
  • Medical Oncology*
  • Outcome Assessment, Health Care*
  • Patient Participation
  • Patient-Centered Care*
  • Pyrazoles / therapeutic use
  • United States
  • United States Food and Drug Administration

Substances

  • Antineoplastic Agents
  • INCB018424
  • Pyrazoles